Pharmacological and Toxicological Evaluation of Methotrexate and Naproxen in Treating Hepatocellular Carcinoma in Wistar Rat
DOI:
https://doi.org/10.21276/apjhs.2021.8.4.42Keywords:
Portal blood, Bilirubin, Hepatocellular Carcinoma, Methotrexate, Naproxen, DiethylnitrosamineAbstract
The liver is one of the heaviest organs in the body (1.2–1.5 kg) and serve the most important function of maintaining the body’s internal environment. The anatomical location of the liver is key to fulfill this role, as almost all absorption of unknown material into the body takes place in the gut and the portal blood draining the gut flows to the liver, which later controls the release of absorbed nutrients into the systemic circulation. In adding together to its function in metabolizing nutrients, the liver is capable to store and liberate a variety of substrates, vitamins and plays an essential role in drug and bilirubin metabolism. Liver cancer is most of the deadliest disease in the whole world which has been increasing day by day. The present study was aimed to investigate the activity of Methotrexate (MTX) and Naproxen (Np) to reduce the risk of liver cancer induced by Diethylnitrosamine (DENA) on rats. After examination, it was observed that pharmacological assessment of MTX and Np shows positive reactions toward treating DENA-induced Hepatocellular Carcinoma in animals.
Downloads
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2021 Pooja Uniyal, Sandhya Dobhal
This work is licensed under a Creative Commons Attribution 4.0 International License.
Asian Pacific Journal of Health Sciences applies the Creative Commons Attribution (CC-BY) license to published articles. Under this license, authors retain ownership of the copyright for their content, but they allow anyone to download, reuse, reprint, modify, distribute and/or copy the content as long as the original authors and source are cited. Appropriate attribution can be provided by simply citing the original article.